Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
On October 1, 2025, Trump will impose 100% tariffs on imported branded drugs unless production begins in the U.S., citing national security.
On October 1, 2025, President Trump will impose a 100% tariff on imported branded and patented pharmaceuticals unless manufacturers have begun construction on U.S. facilities, defined as breaking ground or being under construction.
The move, based on a national security probe under Section 232, aims to boost domestic production amid concerns over supply chain vulnerabilities.
Exemptions may apply to some EU and Japanese firms under a prior agreement, but details remain unclear.
The administration also launched a new Section 232 investigation into medical equipment and supplies.
Uncertainty persists over eligibility, enforcement, and potential impacts on drug prices and availability, with industry leaders urging clarity and warning of possible disruptions.
El 1 de octubre de 2025, Trump impondrá aranceles del 100% a las drogas de marca importadas a menos que la producción comience en los Estados Unidos, citando la seguridad nacional.